These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33649241)

  • 21. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
    Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
    J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation and function of miR-21-FOXO3a-miR-34b/c signaling in breast cancer.
    Liu X; Feng J; Tang L; Liao L; Xu Q; Zhu S
    Int J Mol Sci; 2015 Jan; 16(2):3148-62. PubMed ID: 25647415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.
    Burrows JA; Willis LK; Perlmutter DH
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1796-801. PubMed ID: 10677536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture.
    Hamada-Tsutsumi S; Onishi M; Matsuura K; Isogawa M; Kawashima K; Sato Y; Tanaka Y
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
    Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
    Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency.
    Marcus NY; Blomenkamp K; Ahmad M; Teckman JH
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1163-72. PubMed ID: 23104507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of PiZ gene products in liver tissue by a monoclonal antibody specific for the Z mutant of alpha 1-antitrypsin.
    Callea F; Brisigotti M; Faa G; Lucini L; Eriksson S
    J Hepatol; 1991 May; 12(3):372-6. PubMed ID: 1940268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
    Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
    Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human.
    Giovannoni I; Callea F; Stefanelli M; Mariani R; Santorelli FM; Francalanci P
    Liver Int; 2015 Jan; 35(1):198-206. PubMed ID: 24529185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained miRNA-mediated knockdown of mutant AAT with simultaneous augmentation of wild-type AAT has minimal effect on global liver miRNA profiles.
    Mueller C; Tang Q; Gruntman A; Blomenkamp K; Teckman J; Song L; Zamore PD; Flotte TR
    Mol Ther; 2012 Mar; 20(3):590-600. PubMed ID: 22252449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild Iron Overload as Seen in Individuals Homozygous for the Alpha-1 Antitrypsin Pi*Z Variant Does Not Promote Liver Fibrogenesis in
    Guldiken N; Hamesch K; Schuller SM; Aly M; Lindhauer C; Schneider CV; Fromme M; Trautwein C; Strnad P
    Cells; 2019 Nov; 8(11):. PubMed ID: 31717526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease.
    Wooddell CI; Blomenkamp K; Peterson RM; Subbotin VM; Schwabe C; Hamilton J; Chu Q; Christianson DR; Hegge JO; Kolbe J; Hamilton HL; Branca-Afrazi MF; Given BD; Lewis DL; Gane E; Kanner SB; Teckman JH
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32379724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.
    Li J; Pak SC; O'Reilly LP; Benson JA; Wang Y; Hidvegi T; Hale P; Dippold C; Ewing M; Silverman GA; Perlmutter DH
    PLoS One; 2014; 9(1):e87260. PubMed ID: 24498058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
    Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector.
    Conlon TJ; Cossette T; Erger K; Choi YK; Clarke T; Scott-Jorgensen M; Song S; Campbell-Thompson M; Crawford J; Flotte TR
    Mol Ther; 2005 Nov; 12(5):867-75. PubMed ID: 16085464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymosin-β4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway.
    Zhu L; Ren T; Zhu Z; Cheng M; Mou Q; Mu M; Liu Y; Yao Y; Cheng Y; Zhang B; Cheng Z
    Cell Physiol Biochem; 2018; 51(3):1389-1398. PubMed ID: 30481761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-34b-5p knockdown attenuates bleomycin-induced pulmonary fibrosis by targeting tissue inhibitor of metalloproteinase 3 (TIMP3).
    Hu RP; Lu YY; Zhang XJ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2273-2279. PubMed ID: 30915776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of miR-34b/c-targeted gene expression program by SUMOylation.
    Li YJ; Du L; Aldana-Masangkay G; Wang X; Urak R; Forman SJ; Rosen ST; Chen Y
    Nucleic Acids Res; 2018 Aug; 46(14):7108-7123. PubMed ID: 29893976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.
    Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH
    Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease.
    Gómez-Mariano G; Matamala N; Martínez S; Justo I; Marcacuzco A; Jimenez C; Monzón S; Cuesta I; Garfia C; Martínez MT; Huch M; Pérez de Castro I; Posada M; Janciauskiene S; Martínez-Delgado B
    Hepatol Int; 2020 Jan; 14(1):127-137. PubMed ID: 31832977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.